Serial 98505393
Live / Applied — Revived — awaiting further action (as of 12 Jan 2026)
What this means for you
Not registered yet, but its 17 Apr 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98505393
- Mark type
- Design / logo
- Filed
- 17 Apr 2024
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Kenneth S. McLaughlin, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of epilepsy, bipolar disorder, major depressive disorder, schizophrenia, migraine headaches, and psychiatric diseases and disorders
Owner
- OWP Pharmaceuticals, Inc., Lisle, IL, US
- OWP Pharmaceuticals, Inc., Naperville, IL, US
Prosecution history
- 12 Jan 2026 — TEAS STATEMENT OF USE RECEIVED
- 12 Jan 2026 — SOU EXTENSION RECEIVED WITH TEAS PETITION
- 12 Jan 2026 — NOTICE OF REVIVAL - E-MAILED
- 12 Jan 2026 — PETITION TO REVIVE-GRANTED
- 12 Jan 2026 — TEAS PETITION TO REVIVE RECEIVED
- 08 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jul 2025 — SOU EXTENSION 1 GRANTED
- 07 Jul 2025 — SOU EXTENSION 1 FILED
- 07 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 07 Jan 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Nov 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Nov 2024 — PUBLISHED FOR OPPOSITION
- 20 Nov 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 30 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Oct 2024 — ASSIGNED TO EXAMINER